Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
QRL-101 by QurAlis for Amyotrophic Lateral Sclerosis: Likelihood of Approval
QRL-101 is under clinical development by QurAlis and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData, Phase...